These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22526153)

  • 1. Meta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies.
    Guo CL; Han FF; Wang HY; Wang L
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1443-8. PubMed ID: 22526153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis.
    Wei B; Zhou Y; Xu Z; Xi B; Cheng H; Ruan J; Zhu M; Hu Q; Wang Q; Wang Z; Yan Z; Jin K; Zhou D; Xuan F; Huang X; Shao J; Lu P
    PLoS One; 2011; 6(11):e27545. PubMed ID: 22114677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls.
    Guan P; Huang D; Yin Z; Zhou B
    Asian Pac J Cancer Prev; 2011; 12(4):1067-72. PubMed ID: 21790253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population.
    Jiao X; Huang J; Wu S; Lv M; Hu Y; Jianfu ; Su X; Luo C; Ce B
    Int J Cancer; 2007 Aug; 121(3):501-5. PubMed ID: 17417784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hOGG1 Ser326Cys polymorphism contributes to digestive system cancer susceptibility: evidence from 48 case-control studies.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Tumour Biol; 2015 Feb; 36(2):1029-38. PubMed ID: 25323581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
    Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
    Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of hOGG1 Ser326Cys polymorphism with gastric cancer risk: a meta-analysis.
    Niu Y; Li F; Tang B; Shi Y; Yu P
    Mol Biol Rep; 2012 Jun; 39(6):6563-8. PubMed ID: 22294108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the association between the hOGG1 Ser326Cys polymorphism and the risk of esophageal squamous cell carcinoma.
    Zhang J; Zhou J; Zhang P; Wang W; Tao S; Wang M
    PLoS One; 2013; 8(6):e65742. PubMed ID: 23762419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies.
    Gu D; Wang M; Zhang Z; Chen J
    Breast Cancer Res Treat; 2010 Jul; 122(2):527-31. PubMed ID: 20054639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
    Li H; Hao X; Zhang W; Wei Q; Chen K
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.
    Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD
    Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.
    Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
    Diagn Pathol; 2014 Jun; 9():108. PubMed ID: 24893568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of hOGG1 Ser326Cys polymorphism with colorectal cancer risk: an updated meta-analysis including 5235 cases and 8438 controls.
    Zhang M; Mo R
    Tumour Biol; 2014 Dec; 35(12):12627-33. PubMed ID: 25227662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study.
    Ma L; Chu H; Wang M; Shi D; Zhong D; Li P; Tong N; Yin C; Zhang Z
    Cancer Sci; 2012 Jul; 103(7):1215-20. PubMed ID: 22463382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking and hOGG1 Ser326Cys polymorphism contribute to lung cancer risk: evidence from a meta-analysis.
    Yin ZB; Hua RX; Li JH; Sun C; Zhu JH; Su X; Ji C; Xiang Q; Hua ZM
    Tumour Biol; 2014 Feb; 35(2):1609-18. PubMed ID: 24085357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.
    Xu Z; Yu L; Zhang X
    Diagn Pathol; 2013 Aug; 8():144. PubMed ID: 23971971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
    Yang SF; Xu YJ; Xie JG; Zhang ZX
    Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of OGG1 Ser326Cys polymorphism with colorectal cancer risk: a meta-analysis.
    Zhang Y; He BS; Pan YQ; Xu YQ; Wang SK
    Int J Colorectal Dis; 2011 Dec; 26(12):1525-30. PubMed ID: 21695387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations.
    Tsukino H; Hanaoka T; Otani T; Iwasaki M; Kobayashi M; Hara M; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Tsugane S
    Cancer Sci; 2004 Dec; 95(12):977-83. PubMed ID: 15596047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hOGG1 Ser326Cys polymorphism and esophageal cancer risk: a meta-analysis of 1,875 cancer cases and 3,041 controls.
    Zhao C; Yang J; Xu L
    Ann Transl Med; 2019 Sep; 7(18):438. PubMed ID: 31700874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.